No End To FGM Without Sustained Commitment and Investment.

 

CALL TO ACTION

HOW TO INVEST TO END FGM?


This year’s International Day of Zero Tolerance for Female Genital Mutilation 2026, “Towards 2030: No end to female genital mutilation without sustained commitment and investment,” highlights the need to have sustained engagement from governments, civil society, communities, philanthropic foundations and the international community. Each act of commitment, whether a policy change, a mentoring initiative, a safe space for dialogue, or a shared story of resilience, represents a step towards a world free from female genital mutilation. Continued and flexible funding is vital to protect past achievements, sustain momentum, and ensure that national and community actors can continue their work with confidence and stability.

As we prepare to discuss how sustained investment can accelerate the end of FGM, we want to ensure you have everything you need to join us and amplify this message within your own networks.

Join us on Thursday, February 5th as we come together to observe the International Day of Zero Tolerance for Female Genital Mutilation.Don't hesitate to Register here to participate!

On 6 February 2026, the UNFPA-UNICEF Joint Programme, together with partners, calls on everyone to renew commitments, safeguard hard-won progress, and ensure that every woman and girl can live free from female genital mutilation.

Share your stories, strategies and investment with the hashtags #Invest2EndFGM and #EndFGM to propel a vital movement that leaves no one behind.

Comments

Popular posts from this blog

Recommendation 2: In addition to training, health workers should have access to capacity-building resources including information, education and communication (IEC) materials and job aids, e.g. clinical guides, handbooks, algorithms, flow charts, anatomical models and other digital/print resources explaining the types of FGM, the associated complications and their management.

Focusing particularly on countries where there is a high prevalence of FGM.

Scaling up cost-effective, evidence-based strategies.